Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant
Clinical trial NCT03862833 · COMPLETED
Trial details
- NCT number
- NCT03862833
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2023-08-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.